跳至主要内容
临床试验/NL-OMON38995
NL-OMON38995已完成4 期

The effect on blood loss of topical and intravenous tranexamic acid in cardiac surgery patients: a randomized placebo-controlled trial - Topical tranexamic acid in cardiac surgery patients

Amphia Ziekenhuis0 个研究点目标入组 750 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
750

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • * Gender; male/ female
  • * Age: * 18 year
  • * Elective cardiac surgical patients
  • o Coronary artery bypass graft (CABG) (conventional, E.CCO)
  • o Aortic valve replacement (AVR) (conventional)
  • o Mitral valve replacement/ Mitral valve repair (MVR/MPL) (conventional)
  • o Tricuspid valve replacement/ Tricuspid valve repair (TVR/ TPL)
  • o Combined procedure (e.g. CABG/ AVR, MVR/AVR, AVR/MAZE)

排除标准

  • * MVR/ MPL (minimal invasive)
  • * Maze (minimal invasive)
  • * AVR (minimal invasive)
  • * off-pump procedures
  • * Acute patients
  • * patient with increased or decreased bleeding tedency (FV leiden, prot C, S deficiency,
  • anti-thrombin deficiency, prothrombinmutation)

研究者

发起方
Amphia Ziekenhuis

相似试验

The effect on blood loss of topical and intravenous... | 临床试验